Search for: "AstraZeneca Pharmaceuticals, LP" Results 21 - 40 of 98
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Feb 2015, 12:00 pm by Greene LLP
AstraZeneca LP et al. was filed under seal on behalf of the federal government in October 2010 by former AstraZeneca employees Paul DiMattia and F. [read post]
17 Nov 2014, 9:59 pm by Patent Docs
AstraZeneca Pharmaceuticals LP et al. v. [read post]
13 Nov 2014, 5:00 am
  Such vaccine litigation (Bexis’ first exposure to a pharmaceutical mass tort) was ultimately adjudged so inimical to the public health that Congress prohibited it. [read post]
26 Oct 2014, 9:17 pm by Patent Docs
AstraZeneca Pharmaceuticals LP et al. v. [read post]
23 Jun 2014, 12:57 pm by Schachtman
Ortho Pharmaceutical Corp., 788 F. 2d 741, 744–745 (11th Cir. 1986). [read post]
3 May 2014, 8:56 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 89 F.3d 594, 596-98 (9th Cir. 1996) (affirming exclusion of Dr. [read post]
8 Dec 2013, 8:02 pm by Patent Docs
Kremers Urban Pharmaceuticals, Inc. et al. 3:13-cv-07299; filed December 3, 2013 in the District Court of New Jersey • Plaintiffs: Astrazeneca AB; Aktiebolaget Hassle; Astrazeneca LP; KBI Inc.; KBI-E Inc. [read post]
13 Nov 2013, 9:14 pm by Patent Docs
The '834 patent is directed to a sterile, pharmaceutically effective budesonide product, which is used to treat asthma in... [read post]
27 Oct 2013, 9:55 pm by Patent Docs
• Defendants: Lupin Ltd.; Lupin Pharmaceuticals... [read post]
19 Sep 2013, 9:53 am by Bexis
The following post is exclusively the work of the Reed Smith side of the blog.Sometimes the smallest, least significant type of lawsuit can illustrate cracks in the edifice of the largest, most consequential litigation. [read post]
29 Apr 2013, 1:35 am by FDABlog HPM
District Court for the District of Columbia granting summary judgment for FDA in a case brought by AstraZeneca Pharmaceuticals LP’s (“AstraZeneca’s”) over the approval of generic versions of the company’s blockbuster antipsychotic drug SEROQUEL (quetiapine fumarate) Tablets. [read post]
8 Nov 2012, 1:43 pm by Eric Guttag
AstraZeneca Pharmaceuticals LP to surprise, and unpleasantly upend the patentee. [read post]
10 Sep 2012, 7:28 pm by FDABlog HPM
In July, after a court battle with FDA that started around mid-March when AstraZeneca Pharmaceuticals LP (“AstraZeneca”) sought to enjoin FDA from granting final ANDA approvals for generic SEROQUEL following FDA’s denial (without comment) of two citizen petitions AstraZeneca submitted to FDA last year concerning labeling carve-out issues, the U.S. [read post]
9 Jul 2012, 7:41 pm by FDABlog HPM
Karst –  In a decision that, unless appealed, marks the end of AstraZeneca Pharmaceuticals LP’s (“AstraZeneca’s”) battle with FDA over the approval of generic versions of the company’s blockbuster antipsychotic drug SEROQUEL (quetiapine fumarate) Tablets, the U.S. [read post]
25 May 2012, 11:32 am by Robert Vrana
Judge Stark cited the Federal Circuit’s recent decision in AstraZeneca Pharmaceuticals LP v. [read post]
16 May 2012, 12:22 pm by Bexis
AstraZeneca Pharmaceuticals, LP, 634 F.3d 1352, 1360-66 (11th Cir. 2011) (plaintiff had not pleaded recoverable economic injury); Polk v. [read post]